STRING: 4932.YJL142C
IRC9 (Increased Recombination Centers protein 9) is a putative uncharacterized protein in Saccharomyces cerevisiae (baker's yeast). It is encoded by the IRC9 gene, also designated as YJL142C in the yeast genome . The protein consists of 130 amino acids with apparent membrane-spanning regions .
IRC9 remains among the approximately 1000 uncharacterized yeast genes that persist despite extensive study of the yeast genome . The "IRC" designation suggests a potential role in recombination processes, though direct experimental evidence for this specific function remains limited . Studying IRC9 is significant because:
It represents an opportunity to expand our understanding of the complete yeast proteome
Characterizing its function could reveal new insights into fundamental cellular processes
S. cerevisiae serves as an important model organism with relevance to eukaryotic biology
Understanding IRC9 could potentially reveal conserved functions across fungal species
It's crucial to distinguish between yeast IRC9 and the iRC9 safety switch system, as they represent entirely different systems that share only a similar abbreviation:
| Feature | Yeast IRC9 | iRC9 Safety Switch |
|---|---|---|
| Full name | Increased Recombination Centers protein 9 | Rapamycin-induced caspase-9-based safety switch |
| Organism | Saccharomyces cerevisiae | Engineered system used in human cells |
| Function | Putative uncharacterized protein | Controlled apoptosis mechanism for cell therapies |
| Composition | 130 amino acid native yeast protein | Fusion protein with FKBP12, FRB domain, and Δcaspase-9 |
| Activation | Unknown | Activated by rapamycin through dimerization |
| Application | Basic yeast biology research | Safety mechanism in CAR-T cell therapy |
The iRC9 system is designed for therapeutic applications where "iRC9 comprises an FKBP12 (107 amino acids) followed by an FRB domain (89 amino acids) and Δcaspase-9," allowing rapamycin to induce dimerization and apoptosis of modified cells .
Several expression systems are suitable for recombinant IRC9 production, each with advantages and limitations:
| Expression System | Advantages | Limitations | Tag Options |
|---|---|---|---|
| E. coli | Rapid growth, high yields, cost-effective | May lack post-translational modifications | His, GST, MBP, trxA |
| Yeast (S. cerevisiae) | Native post-translational modifications, proper folding | Slower growth than bacteria | His, FLAG, GST |
| Insect cells | Complex eukaryotic processing, suitable for membrane proteins | Higher cost, technical complexity | His, FLAG, GFP |
| Mammalian cells | Highest fidelity for eukaryotic proteins | Most expensive, lowest yields | His, FLAG, GFP |
Commercial vendors have successfully expressed IRC9 in E. coli with a His-tag , suggesting this may be a suitable starting point for most research applications. For studies focusing on native function or interactions, the yeast expression system may be more appropriate to maintain relevant post-translational modifications .
Several complementary genomic approaches can be used to investigate IRC9 function:
Knockout analysis: The S. cerevisiae knockout collection includes an IRC9 deletion strain that can be phenotypically characterized under various conditions . This systematic approach allows researchers to observe growth defects or other phenotypes associated with IRC9 deletion.
Transcriptomic profiling: Analysis of IRC9 expression across different conditions can provide functional insights. Previous studies have examined yeast transcriptome dynamics during wine fermentation, which included IRC9 expression data .
Genome-wide interaction screens:
Synthetic genetic array (SGA) analysis to identify genes that interact genetically with IRC9
Chemical-genetic profiling to identify conditions where IRC9 becomes essential
Suppressor screens to identify genes that can compensate for IRC9 loss
Experimental design considerations: When designing IRC9 functional studies, researchers should consider the Solomon four-group design or randomized block design to control for confounding variables and ensure robust results .
Studying uncharacterized proteins presents unique challenges. These methodological approaches can help overcome them:
Integrated multi-omics approach:
Condition-dependent phenotyping:
Test IRC9 knockout under diverse stress conditions (osmotic, oxidative, pH, etc.)
Examine growth in different carbon and nitrogen sources
Assess phenotypes across multiple growth phases
Protein localization and dynamics:
Use fluorescently tagged IRC9 to determine subcellular localization
Examine localization changes under different conditions
Monitor protein turnover rates using pulse-chase experiments
Computational analysis:
Apply homology modeling to predict structure
Use evolutionary conservation patterns to identify functional residues
Implement deep learning approaches to predict protein-protein interactions
The yeast community has developed extensive resources to study uncharacterized proteins, including the ability to construct strains with tagged versions of IRC9 for subcellular localization studies , which could be leveraged for comprehensive characterization.
While direct experimental evidence linking IRC9 to recombination processes is limited in the search results, several methodological approaches can be employed to investigate this potential function:
Recombination rate assays:
Measure spontaneous and induced recombination rates in wild-type vs. IRC9 deletion strains
Use reporter constructs with direct and inverted repeats to detect different types of recombination events
Assess sister chromatid exchange frequencies using fluorescent markers
DNA damage response analysis:
Compare survival of wild-type and IRC9 deletion strains after exposure to DNA damaging agents
Monitor Rad52 foci formation (a marker of recombination centers) in IRC9 mutants
Examine genetic interactions between IRC9 and known recombination genes
Mechanistic studies:
Test for physical interactions between IRC9 and known recombination proteins
Assess DNA binding capability through chromatin immunoprecipitation
Examine localization of IRC9 during recombination events or after DNA damage
The research on Irc20 (another member of the IRC protein family) shows it regulates homologous recombination-dependent increases in 2-μm plasmid levels , suggesting that IRC family proteins may indeed play roles in recombination processes.
Analysis of IRC9 expression patterns can provide important functional clues:
Transcriptional regulation:
Experimental approaches to study regulation:
Promoter analysis to identify transcription factor binding sites
Reporter gene assays to quantify expression under different conditions
ChIP-seq to identify transcription factors that bind the IRC9 promoter
CRISPR-based transcriptional modulators to artificially control IRC9 expression
Post-transcriptional regulation:
Analysis of mRNA stability and translation efficiency
Identification of potential regulatory RNA interactions
Assessment of protein half-life under different conditions
Placing IRC9 within the broader context of yeast cellular processes requires integrative approaches:
Network analysis:
Construct protein-protein interaction networks including IRC9
Analyze genetic interaction profiles to position IRC9 within cellular pathways
Apply gene ontology enrichment analysis to IRC9 interactors
Comparative genomics:
Examine IRC9 conservation across fungal species
Identify synteny patterns (conservation of gene order) around IRC9
Compare expression patterns of IRC9 orthologs in related species
Functional genomics:
Based on the amino acid sequence, IRC9 appears to contain hydrophobic regions consistent with membrane association . To determine membrane topology:
Experimental approaches:
Protease protection assays: Tag IRC9 at N- and C-termini with different epitopes, then determine which regions are protected from protease digestion
Glycosylation mapping: Introduce glycosylation sites at various positions to determine which face the endoplasmic reticulum lumen
Fluorescence microscopy: Use split GFP complementation to determine which regions are exposed to specific cellular compartments
Cysteine accessibility methods: Introduce cysteines at various positions and test their accessibility to membrane-impermeable labeling reagents
Computational prediction:
Apply transmembrane prediction algorithms (TMHMM, HMMTOP, etc.)
Construct hydropathy plots to identify potential membrane-spanning regions
Use structural modeling to predict membrane interaction surfaces
Comparative analysis:
Compare predicted topology with related proteins of known structure
Identify conserved residues that might indicate functional sites
When studying uncharacterized proteins like IRC9, researchers often encounter conflicting or ambiguous data. These methodological approaches can help resolve discrepancies:
Experimental design considerations:
Statistical approaches:
Use appropriate statistical tests for time-series data when analyzing IRC9 expression patterns
Apply Bayesian analysis to integrate prior knowledge with new experimental data
Implement meta-analysis techniques to combine results from multiple studies
Validation strategies:
Confirm findings using multiple independent techniques
Test functionality in both in vivo and in vitro systems
Use CRISPR-based approaches for precise genetic manipulation
Complement genetic studies with biochemical assays
Data integration:
Apply network-based approaches to reconcile seemingly conflicting data
Use machine learning to identify patterns across diverse datasets
Implement systems biology modeling to test whether discrepancies can be explained by condition-specific behaviors
A systematic approach to IRC9 characterization would include:
Phase 1: Basic Characterization
Confirm expression under native conditions
Determine subcellular localization
Establish phenotypic consequences of deletion
Identify conditions that alter expression
Phase 2: Interaction Mapping
Identify protein-protein interactions
Map genetic interactions
Determine DNA/RNA interactions if relevant
Characterize lipid interactions if membrane-associated
Phase 3: Biochemical Characterization
Purify recombinant protein
Assess post-translational modifications
Test for enzymatic activities
Determine structure-function relationships
Phase 4: Systems-Level Analysis
Position within metabolic networks
Identify regulatory relationships
Determine evolutionary conservation
Model cellular consequences of perturbation
Phase 5: Validation
Rescue deletion phenotypes with wild-type and mutant variants
Perform structure-guided mutagenesis
Validate in related species
Connect molecular function to cellular phenotypes
A comprehensive pipeline would utilize the extensive yeast genetic tools available, including the yeast knockout collection , GFP-tagged strains for localization , and genome-scale metabolic models like Yeast9 to integrate findings into a systems-level understanding.
Despite powerful genomic technologies, proteins like IRC9 remain uncharacterized for several reasons:
Technical challenges:
Functional redundancy masks phenotypes in single-gene deletion studies
Condition-specific roles may not be apparent under standard laboratory conditions
Membrane proteins present unique purification and structural determination challenges
Resource allocation:
Research funding tends to focus on proteins with clear biomedical relevance
Proteins with strong phenotypes receive disproportionate attention
Limited researchers specifically focused on uncharacterized genes
Data interpretation difficulties:
Phenome-wide association studies can be difficult to interpret for subtle effects
Big data approaches generate hypotheses that require targeted validation
Multi-functional proteins can show seemingly contradictory experimental results
Approximately 1000 yeast genes remain uncharacterized, with IRC9 among them . This represents an opportunity for fundamental discoveries, as these proteins may reveal novel biological functions or regulatory mechanisms.
Thorough characterization of IRC9 could impact our understanding of eukaryotic biology in several ways:
Fundamental processes: If IRC9 is indeed involved in recombination, its study could reveal new mechanisms or regulatory aspects of this essential process
Evolutionary insights: Comparing IRC9 with potential orthologs in other fungi and eukaryotes could illuminate evolutionary conservation of function and protein structure
Systems biology: Positioning IRC9 within the yeast interactome would enhance our understanding of cellular network organization and robustness
Methodological advances: The process of characterizing IRC9 could drive development of new approaches for studying other uncharacterized proteins
Translational relevance: Discoveries about IRC9 function could potentially inform understanding of related processes in higher eukaryotes, including humans
The yeast S. cerevisiae continues to serve as a powerful model organism for understanding eukaryotic cell biology , making the characterization of its uncharacterized proteome, including IRC9, a valuable scientific endeavor.